Health Canada Relations & Advocacy
Working with regulators and policymakers to improve pathways for pediatric rare disease clinical trials and treatment access.
Navigating regulatory pathways is a critical part of bringing therapies to children with rare diseases. This sub-platform supports dialogue, collaboration, and system-level engagement to help improve clinical trial and treatment access pathways in Canada.
Impact
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Pellentesque tristique ipsum nulla, vel auctor est cursus dictum. Pellentesque ullamcorper aliquam malesuada. Aliquam nisi lorem, pretium finibus odio et, viverra mattis sapien. Sed iaculis eros vel enim porttitor, vitae varius arcu vehicula. Nulla ac massa lacus. Aenean rutrum, enim sit amet dapibus vulputate, risus ante sollicitudin erat, quis finibus erat elit at enim. Pellentesque laoreet, mauris nec consequat posuere, felis ex scelerisque quam, ac cursus quam nisi quis diam. Pellentesque elementum tristique lacus vel malesuada. Nullam id est quam. Morbi aliquet nec libero eget porttitor. Sed et vulputate diam. Etiam venenatis, dui non pellentesque efficitur, nisl nisl tempor felis, id pulvinar risus nisl pretium erat.
Phasellus condimentum porttitor turpis, sed pellentesque elit tincidunt non. Praesent quis mattis est, sed sodales odio. Praesent vitae tortor turpis. Ut eget leo et risus pellentesque pretium vel sed tellus. Sed sodales consequat varius. Pellentesque tempor purus eu sapien iaculis porttitor. Maecenas posuere diam in fermentum tempus. Nulla sed justo eu massa iaculis fringilla. Donec in quam viverra, pharetra orci ac, sagittis mauris.
Members
List members of the sub platform to demonstrate expertise (will need support gathering this information, ideally photo, name, and external title/affiliations)